SCHEMBL5207323

SCHEMBL5207323

CC(C)n1nc(CO)c(Cc2ccncc2)c1Sc1cc(F)cc(F)c1

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FYN P06241 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5211288 0.87 FLT1 (0.35)
SCHEMBL5247663 0.85 P2RX7 (0.32) FYN
SCHEMBL7234617 0.85 GCGR (0.30)
SCHEMBL14564994 0.83 FLT1 (0.33)
SCHEMBL5207787 0.83 FLT1 (0.33)
SCHEMBL5208321 0.82 PDE4D (0.36)
SCHEMBL5210120 0.80 CNR1 (0.32)
SCHEMBL5208599 0.77 CACNA1H (0.32)
SCHEMBL5208158 0.76 FLT1 (0.35)
Hydrochloric Acid SCHEMBL5207976 0.76 FLT1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401826-B1 PYRAZOLE DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS HOFFMANN LA ROCHE (CH) 2007-03-21 EP claimed
EP-1401826-A1 PYRAZOLE DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2004-03-31 EP claimed
US-6538015-B1 Process for their manufacture, pharmaceutical compositions and the use of such compounds in medicine. In particular, the compounds of formula I are inhibitors of the human immunodeficiency virus reverse transcriptase enzyme which is HOFFMANN-LA ROCHE INC. 2003-03-25 US claimed
WO-2002100853-A1 PYRAZOLE DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2002-12-19 WO claimed